5-azacytidine enhances the anti-leukemic activity of lintuzumab (SGN-33) in preclinical models of acute myeloid leukemia

M.K. Sutherland, C.P. Yu, M. Anderson, W.P. Zeng, N. van Rooijen, E.L. Sievers, I.S. Grewal, C.L. Law

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)440-448
JournalMABS
Volume2
Issue number4
DOIs
Publication statusPublished - 2010

Cite this